levalbuterol has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bollu, V; Braman, SS; Ernst, FR; Karafilidis, J; Rajagopalan, K; Robinson, SB | 1 |
| Brunetti, L; Dhanaliwala, F; Kang, H; Poiani, G; Poppiti, K; Suh, DC | 1 |
1 trial(s) available for levalbuterol and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma.
Topics: Adolescent; Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Female; Hospitalization; Humans; Length of Stay; Levalbuterol; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Treatment Outcome; Young Adult | 2015 |
1 other study(ies) available for levalbuterol and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Albuterol; Bronchodilator Agents; Chi-Square Distribution; Comparative Effectiveness Research; Ethanolamines; Female; Formoterol Fumarate; Humans; Levalbuterol; Logistic Models; Lung; Male; Middle Aged; Multivariate Analysis; Nebulizers and Vaporizers; Odds Ratio; Patient Readmission; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; United States | 2013 |